CDRH-2023-118641 DIDSR2023-33705-Glass Pathology Slides of Cancer.

Closed Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
FDA-RFQ-CDRH-2023-118641-DIDSR2023
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
College Park, Maryland 20740, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Food and Drug Administration seeks to procure 150 glass slides stained with hematoxylin and eosin from triple negative breast cancer patients within the last seven years, excluding tissue from patients receiving therapy, with required primary metadata provided. Optional line items include additional slides and loaned slides, as well as secondary metadata and surge support. Proposals are due by September 6, 2023 and the purpose is to create datasets to validate digital pathology devices and models by studying data collection and analysis methods.

There is no set-aside designated for this procurement. Slides are to be shipped within one year of award, with the place of performance being 9591 Baltimore Ave, College Park, MD 20740. The solicitation also allows for up to 1,000 extra slides and metadata to be provided within one year as surge support.

Notice text

The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure a CDRH-2023-118641 DIDSR2023-33705 - Glass Pathology Slides of Cancer, under solicitation FDA-RFQ-CDRH-2023-118641-DIDSR2023-33705. This cancels any previous RFQ posted on SAM.gov related to this requirement. Please, respond ASAP.

Files

File Type Posted
FDA-RFQ-Rev CDRH-2023-118641 DIDSR2023-33705 - Glass Pathology r.docx DOCX document

Notice history

Notice Type Posted
CFSAN-2024-121654-400MHZ-NMR Spectrometer Food Screening System Latest solicitation Solicitation
This notice Solicitation
CFSAN-2023-116652 Sciclone G3 NGSxiQ Workstations Pre-Solicitation
Nexcelom Celigo S Cytometer- Control Module-upgrade and Software installation Pre-Solicitation
158 Severe Combined Immunodeficient (SCID) Mice for Animal Study Original Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors